Haskologlu, S. Et Al. 2018. Outcome of treosulfan-based reduced-toxicity conditioning regimens for HSCT in high-risk patients with primary immune deficiencies. PEDIATRIC TRANSPLANTATION , no.7 .

Haskologlu, S., Bal, S. K., Islamoglu, C., Altun, D., KENDİRLİ, T., DOĞU, E. F., ... İKİNCİOĞULLARI, K. A.(2018). Outcome of treosulfan-based reduced-toxicity conditioning regimens for HSCT in high-risk patients with primary immune deficiencies. PEDIATRIC TRANSPLANTATION , no.7.

Haskologlu, ZEHRA Et Al. "Outcome of treosulfan-based reduced-toxicity conditioning regimens for HSCT in high-risk patients with primary immune deficiencies," PEDIATRIC TRANSPLANTATION , no.7, 2018

Haskologlu, ZEHRA Ş. Et Al. "Outcome of treosulfan-based reduced-toxicity conditioning regimens for HSCT in high-risk patients with primary immune deficiencies." PEDIATRIC TRANSPLANTATION , no.7, 2018

Haskologlu, S. Et Al. (2018) . "Outcome of treosulfan-based reduced-toxicity conditioning regimens for HSCT in high-risk patients with primary immune deficiencies." PEDIATRIC TRANSPLANTATION , no.7.

@article{article, author={ZEHRA ŞULE HASKOLOĞLU Et Al. }, title={Outcome of treosulfan-based reduced-toxicity conditioning regimens for HSCT in high-risk patients with primary immune deficiencies}, journal={PEDIATRIC TRANSPLANTATION}, year=2018}